Program Leaders: Carolyn J. Heckman, PhD and Elisa V. Bandera, MD, PhD
To engage in scientific discovery across the cancer control continuum (e.g., primary prevention to survivorship) that translates into empirically-based interventions, clinical and public health practice, and policy strategies to reduce the cancer burden in New Jersey and beyond.
- Advance the understanding of multi-level determinants of cancer risk, treatment, and patient-reported and survival outcomes with an emphasis on minorities and underrepresented populations.
- Characterize and prevent tobacco use and guide effective tobacco control strategies at multiple levels to reduce cancer morbidity and mortality.
- Enhance cancer risk reduction, screening behaviors, and outcomes through the development and evaluation of novel interventions and implementation science.
Collaborating Research Programs:
- Cancer Metabolism and Immunology
- Genomic Instability and Cancer Genetics
- Cancer Pharmacology
- Clinical Investigations and Precision Therapeutics
- List of Program Members
- CALENDAR: Program Meetings, Lectures and other events for Research Members
- Cancer Prevention and Control Selected Program-Related Publications
- Rutgers School of Public Health, Department of Health Behavior, Society and Policy (HBSP)
- Rutgers School of Public Health, Center for Tobacco Studies (CTS)
- Rutgers School of Public Health Department of Biostatistics and Epidemiology
- Screen NJ
- State of NJ Department of Health – Cancer Epidemiology Services (CES)(State Cancer Registry)